And the pharmaceutical company focused on cortisol-related disorders could rise even more due to strong growth prospects. But another likely reason is Big Money lifting the stock.
Corcept Attracts Big Money
So, what’s Big Money? Said simply, that’s when a stock goes up in price alongside chunky volumes. It’s indicative of institutions betting on the shares.
Smart money managers are always looking for the next hot stock. And Corcept has many fundamental qualities that are attractive.
This sets up well for the stock going forward. But how the shares have been trading points to more upside. As I’ll show you, the Big Money has been consistent in the shares.
You see, fund managers are always looking to bet on the next outlier stocks…the best in class. They spend countless hours sizing up companies, reading reports, speaking to analysts…you name it. When they find a company firing on all cylinders, they pounce in a big way.
That’s why I’ve learned how critical it is to gauge Big Money demand for shares. To show you what I mean, have a look at all the Big Money signals CORT has made the last year.
The last few weeks have seen Big Money activity, too. Each green bar signals big trading volumes as the stock ramped in price:
In the last year, the stock attracted nine Big Money buy signals. Generally speaking, recent green bars could mean more upside is ahead.
Now, let’s check out technical action grabbing my attention:
- 1-month outperformance vs. Health Care Select Sector SPDR ETF (+1.0% vs. XLV)
Outperformance is important for leading stocks.
Corcept Fundamental Analysis
Next, it’s a good idea to check under the hood, meaning I want to make sure the fundamental story is strong too. As you can see, Corcept has been growing sales and earnings at double-digit rates. Take a look:
- 3-year sales growth rate (+13.6%)
- 3-year EPS growth rate (+14.5%)
Marrying great fundamentals with technically superior stocks is a winning recipe over the long-term.
In fact, CORT has been a top-rated stock at my research firm, MAPsignals, for years. That means the stock has buy pressure, strong technicals, and growing fundamentals. We have a ranking process that showcases stocks like this on a weekly basis.
CORT has a lot of qualities that are attracting Big Money. It’s made this list 25 times since 2017, with its first appearance on 03/14/2017…and gaining 141.4% since. The blue bars below show the times that Corcept was a top pick:
It’s been a top stock in the health care sector according to the MAPsignals process. I wouldn’t be surprised if CORT makes additional appearances in the years to come. Let’s tie this all together.
Corcept Price Prediction
The Corcept rally could have further to go. Big Money buying in the shares is signaling to take notice. Shares could be positioned for further upside. Given the historical gains in share price and strong fundamentals, this stock could be worth a spot in a diversified portfolio.
Disclosure: the author holds long positions in CORT in managed and personal accounts at the time of publication.
Learn more about the MAPsignals process here.